American Journal of Cardiology
Volume 104, Issue 2 , Pages 175-181 , 15 July 2009

Predictors of Early Discontinuation of Evidence-Based Medicine After Acute Coronary Syndrome

  • Chiara Melloni, MD, MHS

      Affiliations

    • Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
    • Corresponding Author InformationCorresponding author: Tel: 919-668-8646; fax: 919-668-7057
    • ,
  • Karen P. Alexander, MD

      Affiliations

    • Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
    • ,
  • Fang-Shu Ou, MS

      Affiliations

    • Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
    • ,
  • Nancy M. Allen LaPointe, PharmD

      Affiliations

    • Division of Clinical Pharmacology, Duke University Medical Center, Durham, North Carolina
    • ,
  • Matthew T. Roe, MD, MHS

      Affiliations

    • Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
    • ,
  • L. Kristin Newby, MD, MHS

      Affiliations

    • Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
    • ,
  • Khaula Baloch, BA

      Affiliations

    • Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina
    • ,
  • P. Michael Ho, MD, PhD

      Affiliations

    • Division of Cardiology, Denver VA Medical Center and University of Colorado Health Sciences Center, Denver, Colorado
    • ,
  • John S. Rumsfeld, MD, PhD

      Affiliations

    • Division of Cardiology, Denver VA Medical Center and University of Colorado Health Sciences Center, Denver, Colorado
    • ,
  • Eric D. Peterson, MD, MPH

      Affiliations

    • Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina

Received 22 January 2009 ,Revised 8 March 2009 ,Accepted 8 March 2009.

References 

  1. Peterson ED, Roe MT, Mulgund J, DeLong ER, Lytle BL, Brindis RG, et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA. 2006;295:1912–1920
  2. Gore JM, Spencer FA, Goldberg RJ, Kennelly BM, Fox KA, Allegrone J, et al. Use of heparins in non–ST-elevation acute coronary syndromes. Am J Med. 2007;120:63–71
  3. Newby LK, LaPointe NM, Chen AY, Kramer JM, Hammill BG, DeLong ER, et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation. 2006;113:203–212
  4. Mukherjee D, Fang J, Chetcuti S, Moscucci M, Kline-Rogers E, Eagle KA. Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation. 2004;109:745–749
  5. Ellrodt G, LaBresh K, Chen A, Chang H, Bufalino V, Peterson ED, et al. The American Heart Association's Get with the Guidelines coronary artery disease program is associated with improved care for men and women of all ages (abstract). Circulation. 2005;112(suppl):II-792
  6. LaBresh KA, Ellrodt AG, Gliklich R, Liljestrand J, Peto R. Get with the guidelines for cardiovascular secondary prevention: pilot results. Arch Intern Med. 2004;164:203–209
  7. Glickman SW, Boulding W, Staelin R, Mulgund J, Roe MT, Lytle BL, et al. A framework for quality improvement: an analysis of factors responsible for improvement at hospitals participating in the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA guidelines (CRUSADE) quality improvement initiative. Am Heart J. 2007;154:1206–1220
  8. Roe MT. Success stories: how hospitals are improving care. Am Heart J. 2004;148(suppl):S52–S55
  9. Shah B. Trends in care disparities for patients with acute myocardial infarction in the National Registry of Myocardial Infarction from 1994 to 2006 [abstract]. J Am Coll Cardiol. 2008;51:A236–A270
  10. Eagle KA, Kline-Rogers E, Goodman SG, Gurfinkel EP, Avezum A, Flather MD, et al. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. Am J Med. 2004;117:73–81
  11. Jackevicius CA, Li P, Tu JV. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation. 2008;117:1028–1036
  12. Ho PM, Spertus JA, Masoudi FA, Reid KJ, Peterson ED, Magid DJ, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006;166:1842–1847
  13. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47:555–567
  14. Liang K. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13
  15. Ho PM, Peterson ED, Wang L, Magid DJ, Fihn SD, Larsen GC, et al. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA. 2008;299:532–539
  16. Spertus JA, Kettelkamp R, Vance C, Decker C, Jones PG, Rumsfeld JS, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation. 2006;113:2803–2809
  17. Gehi AK, Ali S, Na B, Whooley MA. Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the Heart and Soul Study. Arch Intern Med. 2007;167:1798–1803
  18. Ho PM, Magid DJ, Shetterly SM, Olson KL, Maddox TM, Peterson PN, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008;155:772–779
  19. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007;297:177–186
  20. O'Connor PJ. Improving medication adherence: challenges for physicians, payers, and policy makers. Arch Intern Med. 2006;166:1802–1804
  21. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–497
  22. Mukherjee D. Improving adherence to medications—can we make this horse drink?. Am Heart J. 2008;155:589–590
  23. Hudson M, Rahme E, Richard H, Pilote L. Comparison of measures of medication persistency using a prescription drug database. Am Heart J. 2007;153:59–65
  24. Choudhry NK, Patrick AR, Antman EM, Avorn J, Shrank WH. Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries. Circulation. 2008;117:1261–1268
  25. Kohl H, Shrank WH. Increasing generic drug use in Medicare Part D: the role of government. J Am Geriatr Soc. 2007;55:1106–1109
  26. Federman AD. Don't ask, don't tell: the status of doctor–patient communication about health care costs. Arch Intern Med. 2004;164:1723–1724
  27. Daugherty SL, Ho PM, Spertus JA, Jones PG, Bach RG, Krumholz HM, et al. Association of early follow-up after acute myocardial infarction with higher rates of medication use. Arch Intern Med. 2008;168:485–491
  28. Smith DH, Kramer JM, Perrin N, Platt R, Roblin DW, Lane K, et al. A randomized trial of direct-to-patient communication to enhance adherence to beta-blocker therapy following myocardial infarction. Arch Intern Med. 2008;168:477–483

 MAINTAIN is funded by Bristol-Myers Squibb/Sanofi-Aventis Pharmaceuticals partnership and by Merck Schering-Plough Pharmaceutical.

PII: S0002-9149(09)00726-7

doi: 10.1016/j.amjcard.2009.03.013

American Journal of Cardiology
Volume 104, Issue 2 , Pages 175-181 , 15 July 2009

Article Tools

* Image Usage & Resolution